Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 9Gastrointestinal 3Thoracic 1CNS 1

Conditions

Venous Thrombosis 1Venous Thromboembolism 1Pulmonary Embolism 1Gliosarcoma 1Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pulmonary Embolism × Dalteparin × CNS × Clear all
NCT00135876 2007-04-27

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Ontario Clinical Oncology Group (OCOG)

Phase 3 Completed
512 enrolled
CNSClassical hematology

Brain Neoplasms, Glioma, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡